DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 209 filers reported holding DEPOMED INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $122,000 | +5.2% | 18,362 | +4.4% | 0.00% | 0.0% |
Q1 2018 | $116,000 | -12.1% | 17,588 | +7.4% | 0.00% | 0.0% |
Q4 2017 | $132,000 | +43.5% | 16,376 | +2.7% | 0.00% | +50.0% |
Q3 2017 | $92,000 | -44.2% | 15,946 | +3.8% | 0.00% | -50.0% |
Q2 2017 | $165,000 | -9.3% | 15,361 | +5.8% | 0.00% | -20.0% |
Q1 2017 | $182,000 | -24.8% | 14,521 | +7.9% | 0.01% | -28.6% |
Q4 2016 | $242,000 | -23.4% | 13,457 | +6.5% | 0.01% | -22.2% |
Q3 2016 | $316,000 | +35.0% | 12,633 | +5.8% | 0.01% | +28.6% |
Q2 2016 | $234,000 | +55.0% | 11,944 | +10.3% | 0.01% | +40.0% |
Q1 2016 | $151,000 | -14.7% | 10,826 | +11.1% | 0.01% | -16.7% |
Q4 2015 | $177,000 | +5.4% | 9,748 | +9.7% | 0.01% | 0.0% |
Q3 2015 | $168,000 | -5.6% | 8,886 | +7.3% | 0.01% | +20.0% |
Q2 2015 | $178,000 | +0.6% | 8,283 | +4.7% | 0.01% | 0.0% |
Q1 2015 | $177,000 | +45.1% | 7,908 | +4.6% | 0.01% | +400.0% |
Q4 2014 | $122,000 | +9.9% | 7,557 | +3.6% | 0.00% | 0.0% |
Q3 2014 | $111,000 | – | 7,297 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |